相关因素 | 治疗效果 | c2/Z值 | P值 | |
有效 | 无效 | |||
性别 |
|
|
|
|
男 | 30 | 6 | 0.018 | 0.892 |
女 | 51 | 11 | ||
年龄 |
|
|
|
|
≤65岁 | 37 | 5 | 1.518 | 0.218 |
>65岁 | 44 | 12 | ||
BMI (kg/m2) |
|
|
|
|
≤24 | 38 | 7 | 0.186 | 0.666 |
>24 | 43 | 10 | ||
治疗组别(例) |
|
|
|
|
观察组 | 46 | 3 | 8.611 | 0.003 |
对照组 | 35 | 14 | ||
白细胞计数(109/L) | 11.136 ± 2.715 | 14.153 ± 1.764 | −3.017 | <0.001 |
中性粒细胞计数(109/L) | 8.632 ± 1.375 | 11.437 ± 1.875 | −3.592 | <0.001 |
中性粒细胞百分比(%) | 81.785 ± 6.327 | 87.177 ± 4.763 | −5.391 | 0.001 |
红细胞计数(1012/L) | 4.102 ± 0.443 | 3.899 ± 0.578 | 0.125 | 0.108 |
血红蛋白(g/L) | 128.938 ± 14.717 | 123.882 ± 17.660 | 4.067 | 0.217 |
血小板计数(109/L) | 318.765 ± 62.632 | 330.015 ± 64.740 | 17.178 | 0.514 |
C-反应蛋白(mg/L) | 27.271 ± 23.651 | 81.166 ± 36.951 | 7.026 | <0.001 |
降钙素原(ng/mL) | 0.191 ± 0.222 | 0.765 ± 0.279 | 0.621 | <0.001 |
D-二聚体(mg/L) | 1.817 ± 2.163 | 2.772 ± 4.384 | 0.273 | 0.075 |